FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367303929> ?p ?o ?g. }

• W4367303929 abstract "<h3>Objective:</h3> To describe the risk of depression among individuals with Huntington disease (HD; manifest) versus non-HD registry controls utilizing Enroll-HD data. <h3>Background:</h3> While high rates of depression have been reported in HD, real-world data on depression risk and risk factors in individuals with versus without HD by disease stage are incomplete. <h3>Design/Methods:</h3> Enroll-HD is a global observational registry for individuals with or at risk for HD, and their relatives. Data were collected annually (2013–31 October 2020; manifest, n=10,917; non-HD, n=4996). HD stage was estimated via Total Functional Capacity (TFC) score and Shoulson-Fahn staging: TFC 7–13/stage 1–2 (early), TFC 3–6/stage 3 (middle), TFC 0–2/stage 4–5 (late). Chorea severity was measured by Total Maximal Chorea (TMC) score (TMC 0–7/mild; TMC 8–28/moderate-to-severe), and depression by the Problem Behavioral Assessment binary scale. Odds ratios (ORs) were estimated via a logistic regression model controlling for multiple risk factors. <h3>Results:</h3> Early (OR, 1.84) and middle (1.45) TFC groups were associated with significantly higher risk of depression relative to the non-HD group (both <i>P</i><.001), but not the late group (1.10; <i>P</i>>.25). Depression risk was lower in moderate-to-severe versus mild chorea (0.81, <i>P</i><.001), and for higher versus lower education (0.84, <i>P</i><.001). Depression risk was higher for the following (all <i>P</i><.01): ages 31–60 versus ≤30 years (1.18), females (1.53), overweight versus normal weight (1.13), obese versus normal weight (1.19), antipsychotic agents use (1.27), antidepressant agents use (1.58), smoking (1.18), alcohol problems (1.26), and drug abuse (1.32). <h3>Conclusions:</h3> Depression risk was higher in participants with versus without HD, with an increased risk during early HD stages, even after controlling for relevant risk factors for depression. These findings emphasize the need for attention to depression in early HD. <b>Disclosure:</b> Dr. Reshef has received personal compensation for serving as an employee of Teva. The institution of Mr. Smith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cytel Inc.. The institution of Dr. Harari has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cytel Inc.. Dr. Gordon has received personal compensation for serving as an employee of Teva. Dr. Gordon has stock in Teva. Rinat Ribalov has received personal compensation for serving as an employee of TEVA. Dr. Lengil has received personal compensation for serving as an employee of Teva Pharmaceuticals. Dr. Leo has received personal compensation for serving as an employee of Teva Pharmaceutical Industries. Ms. Willock has received personal compensation for serving as an employee of HCD Economics. Dr. Robles-Zurita has received personal compensation for serving as an employee of HCD Economics. Dr. Robles-Zurita has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for HCD Economics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Furr-Stimming has received research support from Cures within Reach. The institution of Dr. Furr-Stimming has received research support from Huntington’s Disease Society of America. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech." @default.
• W4367303929 created "2023-04-29" @default.
• W4367303929 creator A5010977651 @default.
• W4367303929 creator A5015284385 @default.
• W4367303929 creator A5015826221 @default.
• W4367303929 creator A5028458029 @default.
• W4367303929 creator A5035661780 @default.
• W4367303929 creator A5047715924 @default.
• W4367303929 creator A5055477422 @default.
• W4367303929 creator A5067792222 @default.
• W4367303929 creator A5067840969 @default.
• W4367303929 creator A5083863777 @default.
• W4367303929 creator A5091005645 @default.
• W4367303929 date "2023-04-25" @default.
• W4367303929 modified "2023-10-16" @default.
• W4367303929 title "The Risk of Depression in a Large Huntington Disease Population Compared With Controls: Analysis of the Enroll-HD Registry Data (P1-11.012)" @default.
• W4367303929 doi "https://doi.org/10.1212/wnl.0000000000201885" @default.
• W4367303929 hasPublicationYear "2023" @default.
• W4367303929 type Work @default.
• W4367303929 citedByCount "0" @default.
• W4367303929 crossrefType "proceedings-article" @default.
• W4367303929 hasAuthorship W4367303929A5010977651 @default.
• W4367303929 hasAuthorship W4367303929A5015284385 @default.
• W4367303929 hasAuthorship W4367303929A5015826221 @default.
• W4367303929 hasAuthorship W4367303929A5028458029 @default.
• W4367303929 hasAuthorship W4367303929A5035661780 @default.
• W4367303929 hasAuthorship W4367303929A5047715924 @default.
• W4367303929 hasAuthorship W4367303929A5055477422 @default.
• W4367303929 hasAuthorship W4367303929A5067792222 @default.
• W4367303929 hasAuthorship W4367303929A5067840969 @default.
• W4367303929 hasAuthorship W4367303929A5083863777 @default.
• W4367303929 hasAuthorship W4367303929A5091005645 @default.
• W4367303929 hasConcept C126322002 @default.
• W4367303929 hasConcept C139719470 @default.
• W4367303929 hasConcept C146357865 @default.
• W4367303929 hasConcept C151730666 @default.
• W4367303929 hasConcept C151956035 @default.
• W4367303929 hasConcept C156957248 @default.
• W4367303929 hasConcept C15744967 @default.
• W4367303929 hasConcept C162324750 @default.
• W4367303929 hasConcept C23131810 @default.
• W4367303929 hasConcept C2776867660 @default.
• W4367303929 hasConcept C2778868616 @default.
• W4367303929 hasConcept C2779134260 @default.
• W4367303929 hasConcept C2908647359 @default.
• W4367303929 hasConcept C71924100 @default.
• W4367303929 hasConcept C86803240 @default.
• W4367303929 hasConcept C99454951 @default.
• W4367303929 hasConceptScore W4367303929C126322002 @default.
• W4367303929 hasConceptScore W4367303929C139719470 @default.
• W4367303929 hasConceptScore W4367303929C146357865 @default.
• W4367303929 hasConceptScore W4367303929C151730666 @default.
• W4367303929 hasConceptScore W4367303929C151956035 @default.
• W4367303929 hasConceptScore W4367303929C156957248 @default.
• W4367303929 hasConceptScore W4367303929C15744967 @default.
• W4367303929 hasConceptScore W4367303929C162324750 @default.
• W4367303929 hasConceptScore W4367303929C23131810 @default.
• W4367303929 hasConceptScore W4367303929C2776867660 @default.
• W4367303929 hasConceptScore W4367303929C2778868616 @default.
• W4367303929 hasConceptScore W4367303929C2779134260 @default.
• W4367303929 hasConceptScore W4367303929C2908647359 @default.
• W4367303929 hasConceptScore W4367303929C71924100 @default.
• W4367303929 hasConceptScore W4367303929C86803240 @default.
• W4367303929 hasConceptScore W4367303929C99454951 @default.
• W4367303929 hasLocation W43673039291 @default.
• W4367303929 hasOpenAccess W4367303929 @default.
• W4367303929 hasPrimaryLocation W43673039291 @default.
• W4367303929 hasRelatedWork W167780674 @default.
• W4367303929 hasRelatedWork W1949150524 @default.
• W4367303929 hasRelatedWork W1995615629 @default.
• W4367303929 hasRelatedWork W2030725658 @default.
• W4367303929 hasRelatedWork W2356105190 @default.
• W4367303929 hasRelatedWork W2748952813 @default.
• W4367303929 hasRelatedWork W2765980456 @default.
• W4367303929 hasRelatedWork W2899084033 @default.
• W4367303929 hasRelatedWork W2976382042 @default.
• W4367303929 hasRelatedWork W3191883992 @default.
• W4367303929 isParatext "false" @default.
• W4367303929 isRetracted "false" @default.
• W4367303929 workType "article" @default.